Navigate pharmacoeconomic requirements and HTA frameworks across UAE, Saudi Arabia, and Kuwait markets.
Pharmacoeconomics in GCC Markets: A Practical Guide
By Mohammad Ashour
Category: Market Research
Frequently Asked Questions
Do GCC countries require pharmacoeconomic dossiers?
While not universally mandated, pharmacoeconomic evaluations are increasingly requested for high-cost therapies, particularly in UAE and Saudi Arabia.